Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
on page 1 showing 20 out of 603 results from 1 sources
https://web.expasy.org/cellosaurus/CVCL_0548

Cite this: (IZSLER Cat# BS TCL 90, RRID:CVCL_0548)
Organism: Homo sapiens
Disease: Osteosarcoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 771. Doubling time: ~43 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for a TP53 deletion (PubMed=2823272). Omics: Deep exome analysis. Omics: DNA methylation analysis. Discontinued: ATCC; CRL-7939. Discontinued: KCLB; 80023.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0617

Cite this: (ATCC Cat# HTB-23, RRID:CVCL_0617)
Organism: Homo sapiens
Disease: Invasive lobular breast carcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: FGFR genetic alteration cell panel (ATCC TCP-1034). Part of: ICBP43 breast cancer cell line panel. Part of: MD Anderson Cell Lines Project. Doubling time: 6.4 days (PubMed=9671407). Omics: CNV analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: miRNA expression profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: MDA-MB-134IV; In Cosmic 1000129. Misspelling: MDA-MB-134-IV; In Cosmic 1090333. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0617

Cite this: (IZSLER Cat# BS TCL 236, RRID:CVCL_0617)
Organism: Homo sapiens
Disease: Invasive lobular breast carcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: FGFR genetic alteration cell panel (ATCC TCP-1034). Part of: ICBP43 breast cancer cell line panel. Part of: MD Anderson Cell Lines Project. Doubling time: 6.4 days (PubMed=9671407). Omics: CNV analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: miRNA expression profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: MDA-MB-134IV; In Cosmic 1000129. Misspelling: MDA-MB-134-IV; In Cosmic 1090333. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0618

Cite this: (ATCC Cat# HTB-24, RRID:CVCL_0618)
Organism: Homo sapiens
Disease: Breast carcinoma
Category: Cancer cell line
Comment: Group: Triple negative breast cancer (TNBC) cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ICBP43 breast cancer cell line panel. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Doubling time: 2.8 days (PubMed=9671407). Microsatellite instability: Stable (MSS) (PubMed=15677628; Sanger). Omics: CNV analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: miRNA expression profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: MDA-MB-15; In Cosmic 897421. Discontinued: BCRJ; 0319. Derived from metastatic site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0L89

Cite this: (RRID:CVCL_0L89)
Organism: Homo sapiens
Disease: Melanoma
Category: Cancer cell line
Comment: From: Scott and White Clinic; Temple; Texas; USA.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0832

Cite this: (ATCC Cat# CRL-7395, RRID:CVCL_0832)
Organism: Homo sapiens
Disease: Fibrosarcoma
Category: Cancer cell line
Comment: Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Microsatellite instability: Stable (MSS) (Sanger). Omics: Deep exome analysis. Omics: DNA methylation analysis. Discontinued: ATCC; CRL-7395.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_3951

Cite this: (RRID:CVCL_3951)
Organism: Homo sapiens
Disease: Melanoma
Category: Cancer cell line
Comment: Doubling time: 46 hours (PubMed=1161259).

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_1E89

Cite this: (RRID:CVCL_1E89)
Organism: Homo sapiens
Disease: Melanoma
Category: Cancer cell line
Comment: From: Scott and White Clinic; Temple; Texas; USA. Doubling time: 26 hours, at 10th passage (PubMed=994214).

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_1649

Cite this: (IZSLER Cat# BS TCL 57, RRID:CVCL_1649)
Organism: Homo sapiens
Disease: Embryonal rhabdomyosarcoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel. Doubling time: 23 hours (PubMed=20922763). Microsatellite instability: Stable (MSS) (Sanger). Omics: Cell surface proteome. Omics: Deep exome analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: ATCC; CRL-7713. Discontinued: ATCC; CRL-7731.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0021

Cite this: (RCB Cat# RCB0461, RRID:CVCL_0021)
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: JFCR39 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 24 hours (PubMed=25984343); 23.8 hours (NCI-DTP). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0461.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0021

Cite this: (ICLC Cat# HTL99014, RRID:CVCL_0021)
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: JFCR39 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 24 hours (PubMed=25984343); 23.8 hours (NCI-DTP). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0461.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0020

Cite this: (BCRJ Cat# 0239, RRID:CVCL_0020)
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Doubling time: ~70 hours (DSMZ). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep RNAseq analysis. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0020

Cite this: (ATCC Cat# HTB-16, RRID:CVCL_0020)
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Doubling time: ~70 hours (DSMZ). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep RNAseq analysis. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0020

Cite this: (DSMZ Cat# ACC-291, RRID:CVCL_0020)
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Doubling time: ~70 hours (DSMZ). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep RNAseq analysis. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0020

Cite this: (CLS Cat# 300363/p511_U-138_MG, RRID:CVCL_0020)
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Doubling time: ~70 hours (DSMZ). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep RNAseq analysis. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0021

Cite this: (NCI-DTP Cat# U-251, RRID:CVCL_0021)
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: JFCR39 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 24 hours (PubMed=25984343); 23.8 hours (NCI-DTP). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0461.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0021

Cite this: (CLS Cat# 300385/p534_U251_MG, RRID:CVCL_0021)
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: JFCR39 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 24 hours (PubMed=25984343); 23.8 hours (NCI-DTP). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0461.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0021

Cite this: (KCB Cat# KCB 200965YJ, RRID:CVCL_0021)
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: JFCR39 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 24 hours (PubMed=25984343); 23.8 hours (NCI-DTP). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0461.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0021

Cite this: (ECACC Cat# 09063001, RRID:CVCL_0021)
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: JFCR39 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 24 hours (PubMed=25984343); 23.8 hours (NCI-DTP). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0461.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0021

Cite this: (IFO Cat# IFO50288, RRID:CVCL_0021)
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: JFCR39 cancer cell line panel. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 24 hours (PubMed=25984343); 23.8 hours (NCI-DTP). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Array-based CGH. Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0461.

  • From Current Category

  1. Resource Identification Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Save Your Search

    You can save any searches you perform for quick access to later from here.

  6. Query Expansion

    We recognized your search term and included synonyms and inferred terms along side your term to help get the data you are looking for.

  7. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  8. Sources

    Here are the sources that were queried against in your search that you can investigate further.

  9. Categories

    Here are the categories present within RRID that you can filter your data on

  10. Subcategories

    Here are the subcategories present within this category that you can filter your data on

  11. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

X